IDH1 and central nervous system cancer: As outlined in the 2021 WHO Classification of Central Nervous System Tumors, adult-type diffuse gliomas are now stratified based on key molecular markers, particularly isocitrate dehydrogenase (IDH) mutation, TERT promoter mutation, and chromosome 7 gain/10 loss, in addition to histopathologic criteria [2].